Data revolution driving flurry of M&A in medtech

The latest Healthtech M&A Market Report from international technology mergers and acquisitions advisors, Hampleton Partners, reveals how big data is fast becoming the common currency that lies at the heart of high-value business models in the healthtech sector.

In addition to booming strategic investment in the sector, the first half of 2018 saw record private equity investment and five multi-billion-dollar deals.

Billions of individual electronic health records (EHR) are replacing paper files and the data from decades of medical research and clinical trials need to be stored. Data management and analytics platforms and medical collaboration software are in demand to take advantage of the huge potential the data revolution offers to advance medicine.

Jonathan Simnett, director and healthtech sector principal, Hampleton Partners, said: “The data revolution is helping transform healthcare and is offering individuals, as well as clinicians, the opportunity to track, manage and improve health states in real-time by using healthtech wearables and personalised apps.

“These trillions of health and well-being data points all need monitoring and analysing to provide the effective diagnostics that practitioners need to improve outcomes.”